Company / SG&A per Share
Biogen SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$16.80
FY2025
5-year range
$15.35 / $17.34
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
#7 of 208
Health Care
What the data says
Among 208 Health Care companies, Biogen is in the bottom 3% for sg&a per share. Improved from $17.34 to $16.80 over the past 2 years.
Based on SEC 10-K filings.
16.80 in FY2025 with a 5-year CAGR of +5.7%. Top quartile in the Health Care sector.
Improved from $17.34 to $16.80 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +2.1%
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 208This company $16.80 Sector average $29.78
▼
-43.6% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 0.6% year-over-year.
- Ranks #7 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.80 | +0.6% |
| FY2024 | $16.69 | -3.8% |
| FY2023 | $17.34 | +10.0% |
| FY2022 | $15.77 | +2.7% |
| FY2021 | $15.35 | +20.9% |
| FY2020 | $12.70 | +13.1% |
| FY2019 | $11.23 | +15.1% |
| FY2018 | $9.76 | +8.9% |
| FY2017 | $8.96 | +0.6% |
| FY2016 | $8.90 | -1.1% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026